Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Aug. 31, 2020 | Oct. 09, 2020 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | AURA SYSTEMS INC | |
Entity Central Index Key | 0000826253 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --02-28 | |
Document Type | 10-Q | |
Document Period End Date | Aug. 31, 2020 | |
Document Fiscal Period Focus | Q2 | |
Document Fiscal Year Focus | 2021 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Incorporation State Country Code | DE | |
Entity File Number | 0-17249 | |
Entity Interactive Data Current | No | |
Entity Common Stock, Shares Outstanding | 62,485,178 |
Condensed Balance Sheets (Unaud
Condensed Balance Sheets (Unaudited) - USD ($) | Aug. 31, 2020 | Feb. 29, 2020 |
Current assets | ||
Cash and cash equivalents | $ 191,731 | $ 19,807 |
Inventory | 104,225 | 90,037 |
Other current assets | 4,583 | 1,487 |
Total current assets | 300,540 | 111,330 |
Non-Current Assets | ||
Total assets | 300,540 | 111,330 |
Current liabilities | ||
Accounts payable | 2,001,516 | 2,537,061 |
Accrued expenses | 682,950 | 1,946,290 |
Customer advances | 440,331 | 440,331 |
Accrued expense-related party | 1,008,328 | |
Accrued interest-notes payable-related party | 338,527 | 262,911 |
Accrued interest-notes payable | 195,962 | 498,698 |
Notes payable, current portion | 231,516 | 983,717 |
Notes payable and accrued interest-related party | 11,752,402 | 11,333,960 |
Total current liabilities | 15,643,205 | 19,011,296 |
Notes payable-related party | 3,000,000 | 3,000,000 |
Notes payable | 183,911 | 0 |
Convertible notes payable | 1,402,971 | 1,402,971 |
Total liabilities | 20,230,087 | 23,414,267 |
Commitments and contingencies (note 7) | ||
Shareholders' deficit | ||
Common stock: $0.0001 par value; 150,000,000 shares authorized at August 31 and February 29, 2020; 61,818,512 and 56,400,874 issued and outstanding at August 31 and February 29, 2020, respectively | 6,180 | 5,639 |
Additional paid-in capital | 444,672,986 | 443,417,452 |
Accumulated deficit | (464,608,713) | (466,726,027) |
Total shareholders' deficit | (19,929,547) | (23,302,937) |
Total liabilities and shareholders' deficit | $ 300,540 | $ 111,330 |
Condensed Balance Sheets (Una_2
Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares | Aug. 31, 2020 | Feb. 29, 2020 |
Statement of Financial Position [Abstract] | ||
Common stock, par value | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 150,000,000 | 150,000,000 |
Common stock, shares issued | 61,818,512 | 56,400,874 |
Common stock, shares outstanding | 61,818,512 | 56,400,874 |
Condensed Statements of Operati
Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Aug. 31, 2020 | Aug. 31, 2019 | Aug. 31, 2020 | Aug. 31, 2019 | |
Income Statement [Abstract] | ||||
Net revenue | $ 5,000 | $ 348,075 | $ 53,633 | $ 348,075 |
Cost of goods sold | 3,466 | 29,208 | 43,859 | 32,097 |
Gross profit | 1,534 | 318,867 | 9,774 | 315,978 |
Operating expenses | ||||
Engineering, research & development | 63,293 | 34,359 | 97,287 | 92,552 |
Selling, general & administration | 432,104 | 211,059 | 775,663 | 508,282 |
Total operating expenses | 495,397 | 245,418 | 872,950 | 600,834 |
Profit (loss) from operations | (493,863) | 73,449 | (863,176) | (284,856) |
Other (income) expense: | ||||
Interest expense, net | 327,123 | 284,788 | 616,810 | 601,803 |
Other income | (2,672,414) | (2,679,414) | ||
Gain on extinguishment of debt | (871,887) | (871,887) | ||
Gain on legal settlement | (46,000) | |||
Income (loss) before income tax provision | 2,723,315 | (211,339) | 2,117,314 | (886,659) |
Income tax provision | ||||
Net income (loss) | $ 2,723,315 | $ (211,339) | $ 2,117,314 | $ (886,659) |
Basic income (loss) per share | $ 0.05 | $ 0 | $ 0.04 | $ (0.02) |
Weighted average shares outstanding-basic | 59,515,727 | 53,863,602 | 58,294,261 | 44,356,148 |
Dilutive income (loss) per share | $ 0.04 | $ 0 | $ 0.04 | $ (0.02) |
Weighted average shares outstanding-dilutive | 63,561,907 | 53,863,602 | 62,340,440 | 44,356,148 |
Condensed Statements of Cash Fl
Condensed Statements of Cash Flows (Unaudited) - USD ($) | 6 Months Ended | |
Aug. 31, 2020 | Aug. 31, 2019 | |
Cash flows from operating activities: | ||
Net income (loss) | $ 2,117,314 | $ (886,659) |
Adjustments to reconcile net income (loss) to cash used in operating activities | ||
Fair Market Value of warrants issued for services | ||
Stock-based compensation expense | 174,076 | |
Gain on write-off of expired liabilities | (3,540,826) | |
Changes in working capital assets and liabilities: | ||
Inventory | (14,189) | |
Other current assets | (3,097) | 8,357 |
Accrued interest on notes payable | 579,971 | 569,590 |
Accts payable, customer deposits and accrued expenses | (145,630) | (105,065) |
Cash used in operating activities | (832,381) | (413,777) |
Cash flows from financing activities | ||
Issuance of common stock | 815,000 | 150,353 |
Payment on notes payable | (35,000) | |
Proceeds from Federal PPP & SBA notes | 224,305 | |
Cash provided by financing activities | 1,004,305 | 150,353 |
Net decrease in cash and cash equivalents | 171,924 | (263,424) |
Beginning cash | 19,807 | 358,209 |
Ending cash | 191,731 | 94,785 |
Cash paid in the period for: | ||
Interest | 2,500 | |
Income taxes | ||
Supplemental schedule of non-cash transactions: | ||
Note payable converted into shares of common stock | $ 267,000 |
Condensed Statements of Shareho
Condensed Statements of Shareholders' Deficit (Unaudited) - USD ($) | Common Stock | Additional Paid-In Capital | Accumulated Deficit | Total |
Beginning balance at Feb. 28, 2019 | $ 5,371 | $ 442,519,092 | $ (464,119,162) | $ (21,594,699) |
Beginning balance, Shares at Feb. 28, 2019 | 53,714,145 | |||
Shares issued for cash | $ 15 | 49,985 | 50,000 | |
Shares issued for cash, Shares | 156,250 | |||
Net loss | (675,321) | (675,321) | ||
Ending balance at May. 31, 2019 | $ 5,386 | 442,569,077 | (464,794,483) | (22,001,283) |
Ending balance, Shares at May. 31, 2019 | 53,870,395 | |||
Beginning balance at Feb. 28, 2019 | $ 5,371 | 442,519,092 | (464,119,162) | (21,594,699) |
Beginning balance, Shares at Feb. 28, 2019 | 53,714,145 | |||
Shares issued for cash | 150,353 | |||
Shares issued for cash, Shares | 658,015 | |||
Net loss | (886,659) | |||
Ending balance at Aug. 31, 2019 | $ 5,540 | 4,429,998,999 | (465,005,822) | (22,001,283) |
Ending balance, Shares at Aug. 31, 2019 | 55,402,545 | |||
Beginning balance at May. 31, 2019 | $ 5,386 | 442,569,077 | (464,794,483) | (22,001,283) |
Beginning balance, Shares at May. 31, 2019 | 53,870,395 | |||
Shares issued for cash | $ 51 | 100,302 | 100,353 | |
Shares issued for cash, Shares | 501,765 | |||
Shares issued for settlement | $ 103 | 329,620 | 329,723 | |
Shares issued for settlement, Shares | 1,030,385 | |||
Net loss | (211,339) | (211,339) | ||
Ending balance at Aug. 31, 2019 | $ 5,540 | 4,429,998,999 | (465,005,822) | (22,001,283) |
Ending balance, Shares at Aug. 31, 2019 | 55,402,545 | |||
Beginning balance at Feb. 29, 2020 | $ 5,639 | 443,417,452 | (466,726,027) | (23,302,937) |
Beginning balance, Shares at Feb. 29, 2020 | 56,400,874 | |||
Shares issued for cash | $ 135 | 234,865 | 235,000 | |
Shares issued for cash, Shares | 1,358,333 | |||
Stock-based compensation expense | 77,599 | 77,599 | ||
Net loss | (606,001) | (606,001) | ||
Ending balance at May. 31, 2020 | $ 5,774 | 443,729,916 | (467,332,029) | (23,596,339) |
Ending balance, Shares at May. 31, 2020 | (57,759,207) | |||
Beginning balance at Feb. 29, 2020 | $ 5,639 | 443,417,452 | (466,726,027) | (23,302,937) |
Beginning balance, Shares at Feb. 29, 2020 | 56,400,874 | |||
Shares issued for cash | 815,000 | |||
Shares issued for cash, Shares | 5,224,997 | |||
Net loss | 2,117,314 | |||
Ending balance at Aug. 31, 2020 | $ 6,180 | 444,672,986 | (464,608,713) | (19,929,547) |
Ending balance, Shares at Aug. 31, 2020 | 61,818,512 | |||
Beginning balance at May. 31, 2020 | $ 5,774 | 443,729,916 | (467,332,029) | (23,596,339) |
Beginning balance, Shares at May. 31, 2020 | (57,759,207) | |||
Shares issued for cash | $ 387 | 579,613 | 580,000 | |
Shares issued for cash, Shares | 3,866,664 | |||
Shares issued for settlement | $ 19 | 266,981 | 267,000 | |
Shares issued for settlement, Shares | 192,641 | |||
Stock-based compensation expense | 96,476 | 96,476 | ||
Net loss | 2,723,315 | 2,723,315 | ||
Ending balance at Aug. 31, 2020 | $ 6,180 | $ 444,672,986 | $ (464,608,713) | $ (19,929,547) |
Ending balance, Shares at Aug. 31, 2020 | 61,818,512 |
Nature of Operations and Summar
Nature of Operations and Summary of Significant Accounting Policies | 6 Months Ended |
Aug. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations Aura Systems, Inc., ("Aura", "We" or the "Company") a Delaware corporation, was founded to engage in the development, commercialization, and sales of products, systems, and components, using its patented and proprietary electromagnetic technology. Aura develops and sells AuraGen ® Basis of Presentation In the opinion of management, the unaudited interim condensed financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. However, the results of operations included in such financial statements may not necessary be indicative of annual results. The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company's audited financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended February 29, 2020 ("Fiscal 2020") filed with the Securities and Exchange Commission ("SEC") on July 13, 2020 ("2020 Form 10-K."). Our fiscal year ends on the last day of February. Accordingly, the current fiscal year is ending on February 28, 2021; we refer to the current fiscal as ("Fiscal 2021"). The prior fiscal year is Fiscal 2020. Significant Accounting Policies For a detailed discussion about the Company's significant accounting policies, refer to Note 2 — "Summary of Significant Accounting Policies," in our financial statements included in Company's 2020 Form 10-K. During the three and six-months ended August 31, 2020, the Company recognized aggregate gains of approximately $2.7 million in connection with the cancellation of certain accounts payable balances and accrued payroll related to unpaid wages and salaries and approximately $0.9 million in connection with demand promissory notes with three persons for which the respective statute of limitations periods have expired. Earnings Per Share The following table sets forth the basic and dilutive earnings per share for the three and six-months ended August 31, 2020. The dilutive earning per share includes only the dilutive incremental effect of additional shares issued on an "as if converted basis" in relation to the convertible notes payable principle amounts outstanding as of August 31, 2020 (see Notes 3 and 6). Three-Months Ended August 31, 2020 Income Shares Per-share (Numerator) (denominator) Amount Basic EPS Income available to common stockholders $ 2,723,315 59,515,727 $ 0.05 Effect of Dilutive Securities Convertible notes payable $ 48,559 4,046,180 $ 0.01 Dilutive EPS Income available to common stockholders plus assumed conversions $ 2,771,874 63,561,907 $ 0.04 Six-Months Ended August 31, 2020 Income Shares Per-share (Numerator) (denominator) Amount Basic EPS Income available to common stockholders $ 2,117,314 58,294,261 $ 0.04 Effect of Dilutive Securities Convertible notes payable $ 97,117 4,046,180 $ 0.02 Dilutive EPS Income available to common stockholders plus assumed conversions $ 2,214,431 62,340,440 $ 0.04 Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Reclassifications Certain prior period amounts have been reclassified to conform to the current year presentation. Recently Issued Accounting Pronouncements In June 2016, the FASB issued Accounting Standards Update 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instrument. |
Going Concern
Going Concern | 6 Months Ended |
Aug. 31, 2020 | |
Going Concern [Abstract] | |
GOING CONCERN | NOTE 2 – GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The unaudited condensed financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. If the Company is unable to generate profits on a sustained basis and is unable to continue to obtain financing for its working capital requirements, it may have to curtail its business sharply or cease business altogether. Substantial additional capital resources will be required to fund continuing expenditures related to our research, development, manufacturing and business development activities. The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to retain its current financing, to obtain additional financing, and ultimately to attain profitability. Beginning with the second quarter of fiscal year 2020, we increased operations of our AuraGen ® |
Notes Payable
Notes Payable | 6 Months Ended |
Aug. 31, 2020 | |
Debt Disclosure [Abstract] | |
NOTES PAYABLE | NOTE 3 – NOTES PAYABLE Non-related party and related party notes payable transaction consisted of the following: Non-Related Party Promissory Notes (see below) August 31, February 29, 2020 Demand promissory notes payable with 1 and 4 individuals as of August 31, 2020 and February 29, 2020, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below) $ 10,000 $ 768,537 Messrs. Abdou notes payable 180,181 215,181 U.S. Payroll Protection Plan loan program 74,405 - U.S. Small Business Administration-Economic Injury Disaster Loan 150,841 - Total Demand and Notes Payable 415,427 983,718 Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details. 264,462 264,462 Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details. 133,178 133,178 Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details. 945,825 945,825 Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details. 59,506 59,506 Total Convertible Promissory Notes 1,402,971 1,402,971 Accrued Interest - notes payable 195,962 498,698 Total Non-Related Party 2,014,360 2,885,387 Notes Payable -Related Party (see Note 6) Convertible Note payable – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details 3,000,000 3,000,000 Kopple Notes Payable-related party , see Kopple Notes, Note 6: 10,909,742 10,494,933 Mel Gagerman Notes Payable, see Gagerman, Note 6: 142,660 139,026 On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company's Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021. 700,000 700,000 Accrued Interest - notes payable- related party 338,527 262,911 Total Related Party 15,090,930 14,596,871 Total notes payable and accrued interest 17,105,289 17,482,258 Less: Current portion $ (12,518,407 ) $ (13,079,287 ) Long-term portion $ 4,586,882 $ 4,402,971 Demand Promissory Notes and Notes Payable The Demand Promissory Notes at August 31 and February 29, 2020 are for one and four individuals, respectively, issued in September 2015 that are payable on demand with an interest rate of 10% per annum. As of August 31, 2020, the principle amount owed to the Mr. Zeitlin, a former director of the Company, was $10,000. In the second quarter of fiscal year 2021, liabilities with respect to $758,537 in principal plus $385,349 in accrued interest were reversed as the related statute of limitations were determined to have expired. This reversal resulted in an aggregate reduction of current liabilities of $1,143,886, the recording of an issuance of 192,641 shares of common stock on the Condensed Balance Sheet as of August 31, 2020, and the recognition of $871,887 as gain on extinguishment of debt on the Condensed Statements of Operations for the three and six-months ended August 31, 2020 . Abdou and Abdou On June 20, 2013, the Company entered into an agreement with two individuals, Mr. M. Abdou and Mr. W. Abdou, for the sale of $125,000 of secured convertible notes payable (the "Notes") and warrants. The Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.50 per share. The warrants were subsequently exercised. The Company recorded $24,470 as a discount, which has been fully amortized. There is a remaining balance of $125,000 as of February 28, 2019. In 2016, the Company and the Company's former Chief Executive Officer, Melvin Gagerman, were named among several other defendants in a lawsuit filed by Messrs. Abdou demanding repayment of loans totaling $125,000 plus accrued interest and exemplary damages. In January 2017, the Company entered into an agreement with all secured creditors other than Mr. W. Abdou and Mr. M. Abdou. In September 2018, the court entered a judgment of approximately $235,000 plus legal fees of in favor of the Messrs. Abdou. The Company subsequently appealed this judgment and, in September 2019, reached a settlement agreement with these creditors for a principal amount of $325,000, of which approximately $180,000 and $215,000 were outstanding as of August 31 and February 29, 2020, respectively. Paycheck Protection Plan Loan During April 2020, the Company ceased operations for approximately 6 weeks in compliance with State of California and the County of Orange public health pronouncements associated with the COVID-19 pandemic. On April 23, 2020, we obtained a Paycheck Protection Program ("PPP") loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred for six months, at which time the balance is payable in 18 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. While we intend to apply for the forgiveness of the PPP Loan, there is no assurance that we will obtain forgiveness of the PPP Loan in whole or in part. As of August 31, 2020, $37,202 was classified as notes payable, non-current and $37,203 was classified as part of notes payable, current portion. Economic Injury Disaster Loan Entities negatively impacted by the COVID-19 pandemic were eligible to apply for loans sponsored by the United States Small Business Administration ("SBA") Economic Injury Disaster Loan ("EIDL Loan") program. On July 1, 2020, the Company received cash proceeds of $149,900 under this program. The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include: interest accrues at 3.75% per annum effective July 1, 2020; the payment schedule contains a one-year deferral period on initial principle and interest payments; the loan term is thirty years; The Company pledged the assets of the Company as collateral for the loan; Convertible Notes Payable Kenmont Capital Partners On May 7, 2013, the Company transferred 4 notes payable with a total principal value of $1,000,000 together with accrued interest, and consulting fees to a senior secured convertible note with a principal value of $1,087,000 ("New Kenmont Note") and warrants to Kenmont Capital Partners LP. The New Kenmont Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants were subsequently exercised. The Company recorded $342,020 as a discount, which has been fully amortized. There was a remaining balance of $549,954 as of August 31 and February 29, 2020, respectively. LPD Investments On May 7, 2013, the Company transferred 2 note payables with a total principal value of $550,000 together with accrued interest to a senior secured convertible note with a principal value of $558,700 ("New LPD Note") and warrants to LPD Investments, Ltd. The New LPD Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants were subsequently exercised. The Company recorded $175,793 as a discount, which has been fully amortized. There is a remaining balance of $163,677 as of August 31 and February 29, 2020, respectively. Guenther On May 7, 2013, the Company entered into an agreement with an individual, Mr. Guenther, for the sale of $750,000 of secured convertible note payable (the "Note") and warrants. The Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants entitle the holder to acquire 1,000,000 shares and have an initial exercise price of $0.75 per share and have a 7-year term. The Company recorded $235,985 as a discount, which has been fully amortized. There is a remaining balance of $232,194 as of August 31 and February 29, 2020, respectively. Dresner and Lempert On June 20, 2013, the Company entered into an agreement with two individuals, Mr. Dresner and Dr. Lempert, for the sale of $200,000 of secured convertible notes payable (the "Notes") and warrants. The Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.50 per share. The warrants were subsequently exercised. The Company recorded $39,152 as a discount, which has been fully amortized. During Fiscal 2020, Dr. Lempert converted his share of the amount outstanding into common shares and the balance outstanding of $59,506 as of August 31 and February 29, 2020, respectively, is for Dresner exclusively. Dalrymple – August 2012 On August 10, 2012, the Company entered into an agreement with an individual, Mr. Dalrymple, for the sale of $1,000,000 of unsecured Convertible Promissory Note. The Convertible Promissory Note balance together with all accrued interest thereon was due and payable on August 10, 2017 and the annual interest rate was 7% per annum and was due to be repaid 5 years from the closing date. On January 11, 2018, the note was renegotiated with a final payment date of January 11, 2023 with an annual interest rate of 5%. The Company recorded $310,723 as a debt discount, which will be amortized over the life of the note . Dalrymple – October 2012 On October 2, 2012, the Company entered into an agreement with an individual, Mr. Dalrymple, for the sale of $500,000 of unsecured Convertible Promissory Note. This Convertible Promissory Note balance together with all accrued interest thereon was due and payable on October 2, 2017 and the annual interest rate was 7% per annum and was due to be repaid 5 years from the closing date. On January 11, 2018, the note was renegotiated with a final payment date of January 11, 2023 with an annual interest rate of 5%. The Company recorded $137,583 as a debt discount, which will be amortized over the life of the note . On January 30, 2017, the Company entered into an agreement entitled First Amendment to Transaction Documents with five of seven secured creditors holding a security interest in all of the Company's assets except for its patents and other intellectual properties. All of the creditors entered into the January 30, 2017 agreement with the exception of Mr. W. Abdou and Mr. M. Abdou. The original agreement dated May 7, 2013 provided that if at least 75% of the stock issuable upon conversion of the convertible notes votes to amend the agreement and/or waive any conditions or defaults, then any such amendments or waivers shall be binding on all secured creditors. The five secured creditors signing the amendment total in excess of 95% of the issuable stock upon conversion and, therefore the agreement is binding on all seven of the secured creditors. The agreement provided that all accrued and unpaid interest will be added to the principal amount. The amended note provided for no interest from November 1, 2016 to February 14, 2018, the date at which the 1-for-7 reverse stock split became effective at which time 80% of the total debt including accrued interest was converted into shares of common stock and a new five year 5% per annum convertible note was issued for the remainder. The new amended and restated senior convertible notes have a maturity date of January 30, 2022. The five creditors and the Company entered into a Second Amendment to Transaction Documents on March 14, 2017 and a Third Amendment to Transaction Documents on April 8, 2017, both of which extended the required date of the stockholder approval of the 1-for-7 reverse stock split, which approval was obtained in January 2018. The amended and restated senior convertible notes also require the Company to make a "Required Cash Payment" as defined in the agreement if the Company receives at least $4,000,000 in aggregate gross proceeds from the sale of equity securities (including securities convertible into equity securities) of the Company in one or a series of related transactions. The Required Cash Payment is equal to the current outstanding balance of the notes, which was approximately $1,005,000 as of August 31 and February 29, 2020, respectively, plus any outstanding accrued interest. |
Accrued Expenses
Accrued Expenses | 6 Months Ended |
Aug. 31, 2020 | |
Payables and Accruals [Abstract] | |
ACCRUED EXPENSES | NOTE 4 – ACCRUED EXPENSES Accrued expenses consisted of the following as of the period referenced below: August 31, February 29, 2020 2020 Accrued payroll and related expenses $ 600,508 $ 1,868,928 Other accrued expenses 77,442 77,362 $ 682,950 $ 1,946,290 Accrued payroll and related expenses consist primarily of salaries and vacation time accrued but not paid to employees due to our lack of financial resources. In the second quarter of fiscal year 2021, liabilities with respect to approximately $1.3 million in accrued payroll and related expenses were reversed as the related statute of limitation periods were determined to have expired. |
Shareholders' Equity
Shareholders' Equity | 6 Months Ended |
Aug. 31, 2020 | |
Stockholders' Equity Note [Abstract] | |
SHAREHOLDERS' EQUITY | NOTE 5 – SHAREHOLDERS' EQUITY Common Stock During the three and six-months ended August 31, 2020, the Company issued 3,866,664 and 5,224,997 shares of common stock, respectively, for $580,000 and $815,000 in cash, respectively. During the three and six-months ended August 31, 2019, the Company issued 501,765 and 658,015 shares of common stock, respectively, for $100,353 and $150,353 in cash, respectively. During August 2019, 1,030,385 shares were issued for a settlement valued at $329,723 and during August 2020, 192,641 shares were issued in connection with the Veen settlement (see Note 3). Employee Options and Warrants The 2006 Employee Stock Option Plan In September 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan, subject to shareholder approval, which was obtained at a special shareholders meeting in 2009. Under the 2006 Plan, the Company may grant options for up to the greater of three million or 10% of the number of shares of the Common Stock of Aura from time to time outstanding. As of February 29, 2020, and August 31, 2020, there were no stock options outstanding. The 2011 Director and Executive Officers Stock Option Plan In October 2011, shareholders approved the 2011 Director and Executive Officers Stock Option Plan at the Company's annual meeting. Under the 2011 Plan, the Company may grant options for up to 15% of the number of shares of Common Stock of the Company from time to time outstanding, with a contractual option term of five-years, and a vesting period not less than six-months and one day following date of grant. In the six-months ended August 31, 2020, the Board of Directors approved grants of 250,000 stock options to each board member for an aggregate of 1,250,000 options, with an exercise price of $0.25 per option and at a market price of $0.16 on March 19, 2020, the date of grant. The following table provides the assumptions required to apply the Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date: Options Exercise Price $ 0.25 Share Price $ 0.16 Volatility % 225 % Risk-free rate 0.57 % Expected term (yrs.) 4.0 The aggregate fair value of the 1,250,000 options granted in March 2020 is $194,000, or $0.155 per option, with $96,477 and $174,076 recorded as part of sales, general and administration expense during the three and six-months ended August 31, 2020, respectively. No stock-based compensation expense was recorded during Fiscal 2020. The following tables provide additional information regarding stock options outstanding and exercisable under the 2011 Director and Executive Officers Stock Option Plan: Number of Shares Exercise Weighted Outstanding, February 29, 2020 1,040,001 $ 1.40 $ - Granted 1,250,000 0.25 - Exrecised - - - Cancelled - - - Outstanding, August 31, 2020 2,290,001 $ 0.77 $ - Range of Exercise Stock Stock Weighted Weighted Weighted $0.25 to $1.40 2,290,001 1,040,001 3.5 Yrs. $ 0.77 $ 1.40 Warrants Historically, warrants have been issued to investors and others for services and enticements to invest funds with the Company. Generally, these warrants fully vest immediately or within a 90-day period from the date of grant and have an expiration date of five-years from the date of grant. With grants dated prior to Fiscal 2021, an exercise price of $1.40 has been used with all warrants. No warrants were issued in the six-months ended August 31, 2020. Activity in issued and outstanding warrants is as follows for the six-months ended August 31, 2020: Number of Exercise Shares Price Outstanding, February 29, 2020 5,816,939 $ 1.40 Granted - - Exrecised - - Cancelled - - Outstanding, August 31, 2020 5,816,939 $ 1.40 Other information related to the warrants outstanding and exercisable as of August 31, 2020 follows: Range of Exercise Stock Stock Weighted Weighted Average Price of Weighted $ 1.40 5,816,939 5,816,939 2.19 Yrs. $ 1.40 $ 1.40 |
Related Parties Transactions
Related Parties Transactions | 6 Months Ended |
Aug. 31, 2020 | |
Related Party Transactions [Abstract] | |
RELATED PARTIES TRANSACTIONS | NOTE 6 – RELATED PARTIES TRANSACTIONS Notes payable-related party, non-current Breslow Note On January 24, 2017, the Company entered into a Debt Refinancing Agreement with Mr. Breslow, a former Director of the Company. Pursuant to the agreement, both Mr. Breslow and the Company acknowledged that total debt owed to Mr. Breslow was $23,872,614 including $8,890,574 of accrued interest. Mr. Breslow agreed to cancel and forgive all interest due, waive all events of default and sign a new five-year convertible note in the amount of $14,982,041 providing for no interest for six months and interest of 5% per annum thereafter payable monthly in arrears. The note also provides various default provisions. In accordance with the agreement, on February 14, 2018, the effective date of the 1-for-7 reverse stock split, $11,982,041 of the note was converted into 7,403,705 shares of common stock and the then accrued interest of $9,388,338 was forgiven. A new $3,000,000 convertible five-year note representing the remaining balance was entered into at a conversion rate of $1.40. The note bears interest at a rate of 5% per annum payable monthly in arrears with accrued interest of $338,527 and $262,911 recorded as accrued interest-related party (see Note 4) as of August 31 and February 29, 2020, respectively. Notes payable and accrued interest-related party, current Kopple Notes As of August 31, and February 29, 2020, the principal amount owed to Robert Kopple (former Vice-Chairman of our Board) of $5,607,323 was unchanged. As of August 31, 2020, accrued interest of $5,302,419 was owed to Mr. Kopple for a total balance of $10,909,742. As of February 29, 2020, accrued interest of $4,887,610 was owed to Mr. Kopple for a total balance of $10,494,933. On August 19, 2013, the Company entered into an agreement with Robert Kopple, a former member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the "Kopple Notes") and warrants. The Kopple Notes carried a base interest rate of 9.5%, have a 4-year maturity date and were convertible into shares of common stock at the conversion price of $3.50 per share (conversion feature expired in 2017). The warrants were subsequently exercised. The Company recorded $667,118 as a discount, which has been fully amortized. The Company also entered into a demand note payable with this individual in the amount of $20,000, which bears interest at a rate of 5% per annum. Gagerman Note On August 31, 2020, the Gagerman note consisted of $82,000 of unsecured note payable plus accrued interest of $60,660 for a total owed to Melvin Gagerman of $142,660, the Company's former CEO and CFO, pursuant to a demand note entered into on April 5, 2014. Interest accrues at 10% per annum. On February 29, 2020, the amount owed to Gagerman was $139,026. Jiangsu Shengfeng Note On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company's Chinese joint venture, to return $700,000 previously advanced to the Company in September 2018 and recorded as part of customer advance on the balance sheet as of February 28, 2019. Following this agreement which would consists of a non-interest-bearing promissory note and a payment plan pursuant to which the $700,000 would be paid over a 12-month period. Principal loan amount on August 31, 2020 and February 29, 2020 was $700,000, respectively, and is classified as part of notes payable and accrued interest-related party, current on the balance sheets as of August 31, 2020. Accrued expense-related party – |
Commitments & Contingencies
Commitments & Contingencies | 6 Months Ended |
Aug. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS & CONTINGENCIES | NOTE 7 – COMMITMENTS & CONTINGENCIES Leases Our facilities consist of approximately 20,000 square feet in Stanton, California and, prior to July 31, 2020, an additional storage facility in Santa Clarita, California. The Stanton facility is used for assembly and testing of AuraGen®/VIPER systems and is rented on a month-to-month basis at $10,000 per month. Prior to July 2020, the Company paid $5,000 per month, on a month-to-month basis, for the Santa Clarita storage facility. Following the closure of this facility, the Company is currently renting on a month-to-month basis approximately 1,000 square feet of temporary offsite storage space at a monthly cost of approximately $2,500. Commencing in February 2019 and ending in July 2019, the Company rented approximately 300 square feet of office space in Irvine, California at a cost of $ 2,350 per month on a month-to-month basis. Following the adoption of Topic 842, Leases, as of the start of Fiscal 2020, the Company determined that there was no impact on its Condensed Financial Statements during the fiscal year ended February 29, 2020, and as of August 31, 2020, it is management's intention to vacate the existing facilities and consolidate operations at a different location as soon as practical. The standard requires entities to evaluate all lease transactions including leases previously classified as operating leases, and, if required under Topic 842, a right-to-use asset and a corresponding lease liability to be recorded on the balance sheet in the period in which a lease commences. Contingencies We are subject to the legal proceedings and claims discussed below as well as certain other legal proceedings and claims that have not been fully resolved and that have arisen in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and evaluates potential losses on such litigation if the amount of the loss is estimable and the loss is probable. However, the outcome of legal proceedings and claims brought against the Company is subject to significant uncertainty. Although management considers the likelihood of such an outcome to be remote, if one or more of these legal matters were resolved against the Company for amounts in excess of management's expectations, the Company's financial statements for that reporting period could be materially adversely affected. In 2017, the Company's former COO was awarded approximately $238,000 in accrued salary and related charges by the California labor board. The Company believes that this award does not reflect the amount owed which is significantly lower and is exploring all its options and available remedies and is working toward an offer to settle this matter. The Company is presently engaged in a dispute with one of its former directors, Robert Kopple, relating to approximately $10.6 million (representing approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced or paid to third parties on Aura's behalf; and approximately $5 million Mr. Kopple claims to be owed for interest, loan fees and late payment charges) and approximately 3.33 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company. In July 2017, Mr. Kopple filed suit against the Company as well as against current director Mr. Diaz-Verson and former directors Mr. Breslow and Mr. Howsmon, as well as Mr. Gagerman, our former CEO and a former director, in connection with these allegations. In 2018, the Court dismissed Mr. Diaz-Verson, Mr. Breslow, Mr. Howsmon and Mr. Gagerman from the suit. While the Company believes that it has certain valid defenses in these matters, the Company is currently in settlement discussions with Mr. Kopple. However, to-date, no settlement has been reached in large part because Mr. Kopple continues to demand that as part of any such settlement, he receive unilateral control over significant aspects of the Company's financial and management functions such as, but not limited to, the right to unilaterally direct the Company's ordinary business expenditures and requiring the Company to seek his approval for the hiring of nearly all personnel, all to the exclusion of the Company's management team and stockholder-elected Board of Directors. The Company believes that allowing Mr. Kopple such level of operational control over the Company without any accountability would be highly detrimental to the Company and is incompatible with the Board of Directors' duties to shareholders and creditors as a whole. In May 2018, Shelley Scholnick dba JB Transporters brought suit against the Company claiming ongoing fees in excess of $52,000 owed for the storage of the Company's property. Notably, in June 2017, the Company had brought suit against J.B. Moving & Delivery, a business operated and controlled by a relative of Scholnick, Jacob Binstok, for damages suffered by the Company as a result of the defendant's improper storage of the Company's property and improper refusal to return such property. In 2018, the Company successfully received a judgment against J.B. Moving & Delivery in the amount of approximately $114,000. In April 2020, Aura and Scholnick entered into a Confidential Settlement and Release Agreement wherein (i) the 2018 action initiated by Scholnick against Aura was resolved with no amounts owing by Aura and the complaint and cross-complaint were subsequently dismissed with prejudice; and (ii) the amount owing to Aura pursuant to the judgment against J.B. Moving and Delivery was compromised and resolved through a single lump-sum payment to Aura. On March 26, 2019, various stockholders of the Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing Ronald Buschur as a member of the Company's Board and electing Cipora Lavut as a director of the Company. On March 27, 2019, those same stockholders delivered a further signed written consent to the Company removing William Anderson and Si Ryong Yu as members of the Company's Board and electing Robert Lempert and David Mann as directors of the Company. These written consents represented a majority of the outstanding shares of the Company's common stock as of March 26, 2019 and March 27, 2019, respectively. Because of Aura's refusal to recognize the legal effectiveness of the consents, on April 8, 2019 the stockholders filed suit in the Court of Chancery of the State of Delaware pursuant to Section 225 of the Delaware General Corporations Law, seeking an order confirming the validity of the consents and declaring that Aura's Board consists of Ms. Lavut, Mr. Mann, Dr. Lempert, Mr. Douglas and Mr. Diaz-Versón, Jr. On July 8, 2019 the Court of Chancery entered final judgment in favor of the stockholder plaintiffs, confirming that (a) Ronald Buschur, Si Ryong Yu and William Anderson had been validly removed by the holders of a majority of the Company's outstanding stock acting by written consent (b) Ms. Lavut, Mr. Mann and Dr. Lempert had been validly elected by the holders of a majority of the Company's outstanding stock acting by written consent, and (c) the Company's Board of Directors validly consists of Cipora Lavut, David Mann, Robert Lempert, Gary Douglas and Salvador Diaz-Versón, Jr. As a result of prior management's unsuccessful opposition to this stockholders' action filed in the Court of Chancery, such stockholders may be potentially entitled to recoup their litigation costs from the Company under Delaware's corporate benefit doctrine and/or other legal provisions. To-date, no final determination has been made as to the amount of recoupment, if any, to which such stockholders may be entitled. |
Nature of Operations and Summ_2
Nature of Operations and Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Aug. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Nature of Operations | Nature of Operations Aura Systems, Inc., ("Aura", "We" or the "Company") a Delaware corporation, was founded to engage in the development, commercialization, and sales of products, systems, and components, using its patented and proprietary electromagnetic technology. Aura develops and sells AuraGen ® |
Basis of Presentation | Basis of Presentation In the opinion of management, the unaudited interim condensed financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. However, the results of operations included in such financial statements may not necessary be indicative of annual results. The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company's audited financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended February 29, 2020 ("Fiscal 2020") filed with the Securities and Exchange Commission ("SEC") on July 13, 2020 ("2020 Form 10-K."). Our fiscal year ends on the last day of February. Accordingly, the current fiscal year is ending on February 28, 2021; we refer to the current fiscal as ("Fiscal 2021"). The prior fiscal year is Fiscal 2020. |
Significant Accounting Policies | Significant Accounting Policies For a detailed discussion about the Company's significant accounting policies, refer to Note 2 — "Summary of Significant Accounting Policies," in our financial statements included in Company's 2020 Form 10-K. During the three and six-months ended August 31, 2020, the Company recognized aggregate gains of approximately $2.7 million in connection with the cancellation of certain accounts payable balances and accrued payroll related to unpaid wages and salaries and approximately $0.9 million in connection with demand promissory notes with three persons for which the respective statute of limitations periods have expired. |
Earnings Per Share | Earnings Per Share The following table sets forth the basic and dilutive earnings per share for the three and six-months ended August 31, 2020. The dilutive earning per share includes only the dilutive incremental effect of additional shares issued on an "as if converted basis" in relation to the convertible notes payable principle amounts outstanding as of August 31, 2020 (see Notes 3 and 6). Three-Months Ended August 31, 2020 Income Shares Per-share (Numerator) (denominator) Amount Basic EPS Income available to common stockholders $ 2,723,315 59,515,727 $ 0.05 Effect of Dilutive Securities Convertible notes payable $ 48,559 4,046,180 $ 0.01 Dilutive EPS Income available to common stockholders plus assumed conversions $ 2,771,874 63,561,907 $ 0.04 Six-Months Ended August 31, 2020 Income Shares Per-share (Numerator) (denominator) Amount Basic EPS Income available to common stockholders $ 2,117,314 58,294,261 $ 0.04 Effect of Dilutive Securities Convertible notes payable $ 97,117 4,046,180 $ 0.02 Dilutive EPS Income available to common stockholders plus assumed conversions $ 2,214,431 62,340,440 $ 0.04 |
Use of Estimates | Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. |
Reclassifications | Reclassifications Certain prior period amounts have been reclassified to conform to the current year presentation. |
Recently Issued Accounting Pronouncements | Recently Issued Accounting Pronouncements In June 2016, the FASB issued Accounting Standards Update 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instrument. |
Nature of Operations and Summ_3
Nature of Operations and Summary of Significant Accounting Policies (Tables) | 6 Months Ended |
Aug. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of earnings Per Share | Three-Months Ended August 31, 2020 Income Shares Per-share (Numerator) (denominator) Amount Basic EPS Income available to common stockholders $ 2,723,315 59,515,727 $ 0.05 Effect of Dilutive Securities Convertible notes payable $ 48,559 4,046,180 $ 0.01 Dilutive EPS Income available to common stockholders plus assumed conversions $ 2,771,874 63,561,907 $ 0.04 Six-Months Ended August 31, 2020 Income Shares Per-share (Numerator) (denominator) Amount Basic EPS Income available to common stockholders $ 2,117,314 58,294,261 $ 0.04 Effect of Dilutive Securities Convertible notes payable $ 97,117 4,046,180 $ 0.02 Dilutive EPS Income available to common stockholders plus assumed conversions $ 2,214,431 62,340,440 $ 0.04 |
Notes Payable (Tables)
Notes Payable (Tables) | 6 Months Ended |
Aug. 31, 2020 | |
Debt Disclosure [Abstract] | |
Schedule of non-related party and related party notes payable transaction | Non-Related Party Promissory Notes (see below) August 31, February 29, 2020 Demand promissory notes payable with 1 and 4 individuals as of August 31, 2020 and February 29, 2020, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below) $ 10,000 $ 768,537 Messrs. Abdou notes payable 180,181 215,181 U.S. Payroll Protection Plan loan program 74,405 - U.S. Small Business Administration-Economic Injury Disaster Loan 150,841 - Total Demand and Notes Payable 415,427 983,718 Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details. 264,462 264,462 Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details. 133,178 133,178 Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details. 945,825 945,825 Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details. 59,506 59,506 Total Convertible Promissory Notes 1,402,971 1,402,971 Accrued Interest - notes payable 195,962 498,698 Total Non-Related Party 2,014,360 2,885,387 Notes Payable -Related Party (see Note 6) Convertible Note payable – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details 3,000,000 3,000,000 Kopple Notes Payable-related party , see Kopple Notes, Note 6: 10,909,742 10,494,933 Mel Gagerman Notes Payable, see Gagerman, Note 6: 142,660 139,026 On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company's Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021. 700,000 700,000 Accrued Interest - notes payable- related party 338,527 262,911 Total Related Party 15,090,930 14,596,871 Total notes payable and accrued interest 17,105,289 17,482,258 Less: Current portion $ (12,518,407 ) $ (13,079,287 ) Long-term portion $ 4,586,882 $ 4,402,971 |
Accrued Expenses (Tables)
Accrued Expenses (Tables) | 6 Months Ended |
Aug. 31, 2020 | |
Payables and Accruals [Abstract] | |
Schedule of accrued expenses | August 31, February 29, 2020 2020 Accrued payroll and related expenses $ 600,508 $ 1,868,928 Other accrued expenses 77,442 77,362 $ 682,950 $ 1,946,290 |
Shareholders' Equity (Tables)
Shareholders' Equity (Tables) | 6 Months Ended |
Aug. 31, 2020 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date | Options Exercise Price $ 0.25 Share Price $ 0.16 Volatility % 225 % Risk-free rate 0.57 % Expected term (yrs.) 4.0 |
Schedule of employee stock option plan | Number of Shares Exercise Weighted Outstanding, February 29, 2020 1,040,001 $ 1.40 $ - Granted 1,250,000 0.25 - Exrecised - - - Cancelled - - - Outstanding, August 31, 2020 2,290,001 $ 0.77 $ - |
Schedule of exercise price options outstanding | Range of Exercise Stock Stock Weighted Weighted Weighted $0.25 to $1.40 2,290,001 1,040,001 3.5 Yrs. $ 0.77 $ 1.40 |
Schedule of activity in issued and outstanding warrants | Number of Exercise Shares Price Outstanding, February 29, 2020 5,816,939 $ 1.40 Granted - - Exrecised - - Cancelled - - Outstanding, August 31, 2020 5,816,939 $ 1.40 |
Schedule of exercise prices warrants outstanding | Range of Exercise Stock Stock Weighted Weighted Average Price of Weighted $ 1.40 5,816,939 5,816,939 2.19 Yrs. $ 1.40 $ 1.40 |
Nature of Operations and Summ_4
Nature of Operations and Summary of Significant Accounting Policies (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Aug. 31, 2020 | Aug. 31, 2019 | Aug. 31, 2020 | Aug. 31, 2019 | |
Basic EPS | ||||
Income (Numerator) income available to common stockholders | $ 2,723,315 | $ 2,117,314 | ||
Shares (denominator) income available to common stockholders | 59,515,727 | 58,294,261 | ||
Per-share amount income available to common stockholders | $ 0.05 | $ 0 | $ 0.04 | $ (0.02) |
Effect of Dilutive Securities | ||||
Income (Numerator) convertible notes payable | $ 48,559 | $ 97,117 | ||
Shares (denominator convertible notes payable | 4,046,180 | 4,046,180 | ||
Per-share amount convertible notes payable | $ 0.01 | $ 0.02 | ||
Dilutive EPS | ||||
Income (Numerator income available to common stockholders plus assumed conversions | $ 2,771,874 | $ 2,214,431 | ||
Shares (denominator) income available to common stockholders plus assumed conversions | 63,561,907 | 62,340,440 | ||
Per-share amount income available to common stockholders plus assumed conversions | $ 0.04 | $ 0.04 |
Going Concern (Details)
Going Concern (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended |
Aug. 31, 2020 | Aug. 31, 2020 | Feb. 29, 2020 | |
Going Concern (Textual) | |||
Recognized revenue | $ 5,000 | $ 53,633 | $ 348,075 |
Notes Payable (Details)
Notes Payable (Details) - USD ($) | Aug. 31, 2020 | Feb. 29, 2020 |
Debt Instrument [Line Items] | ||
Total Demand and Notes Payable | $ 415,427 | $ 983,718 |
Total Convertible Promissory Notes | 1,402,971 | 1,402,971 |
Accrued Interest - notes payable- see Note 7 | 195,962 | 498,698 |
Total Non-Related Party | 2,014,360 | 2,885,387 |
Demand promissory notes payable [Member] | ||
Debt Instrument [Line Items] | ||
Demand and Notes Payble | 10,000 | 768,537 |
Messrs. Abdou notes payable [Member] | ||
Debt Instrument [Line Items] | ||
Demand and Notes Payble | 180,181 | 215,181 |
U.S. Payroll Protection Plan loan program [Member] | ||
Debt Instrument [Line Items] | ||
Demand and Notes Payble | 74,405 | |
Convertible Promissory Note dated August 10, 2012 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible Promissory Notes | 264,462 | 264,462 |
Convertible Promissory Note originally dated October 2, 2012 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible Promissory Notes | 133,178 | 133,178 |
Senior secured convertible notes originally dated May 7, 2013 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible Promissory Notes | 945,825 | 945,825 |
Senior secured convertible notes originally dated June 20, 2013 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible Promissory Notes | 59,506 | 59,506 |
U.S. Small Business Administration-Economic Injury Disaster Loan [Member] | ||
Debt Instrument [Line Items] | ||
Demand and Notes Payble | $ 150,841 |
Notes Payable (Details) (Parent
Notes Payable (Details) (Parenthetical) | Aug. 31, 2020$ / shares |
Convertible Promissory Note originally dated August 10, 2012 [Member] | |
Debt Instrument [Line Items] | |
Notes payable interest rate | 5.00% |
Common stock at price | $ 0.76 |
Convertible Promissory Note originally dated October 2, 2012 [Member] | |
Debt Instrument [Line Items] | |
Notes payable interest rate | 5.00% |
Common stock at price | $ 0.76 |
Senior secured convertible notes originally dated May 7, 2013 [Member] | |
Debt Instrument [Line Items] | |
Notes payable interest rate | 5.00% |
Common stock at price | $ 0.75 |
Senior secured convertible notes originally dated June 20, 2013 [Member] | |
Debt Instrument [Line Items] | |
Notes payable interest rate | 5.00% |
Common stock at price | $ 0.50 |
Notes Payable (Details 1)
Notes Payable (Details 1) - USD ($) | Aug. 31, 2020 | Feb. 29, 2020 |
Debt Instrument [Line Items] | ||
Convertible Note payable | $ 183,911 | $ 0 |
Accrued Interest - notes payable- related party | 338,527 | 262,911 |
Jiangsu Shengfeng [Member] | ||
Debt Instrument [Line Items] | ||
Convertible Note payable | 700,000 | 700,000 |
Accrued Interest - notes payable- related party | 338,527 | 262,911 |
Total Related Party | 15,090,930 | 14,596,871 |
Total notes payable and accrued interest | 17,105,289 | 17,482,258 |
Less: Current portion | (12,518,407) | (13,079,287) |
Long-term portion | 4,586,882 | 4,402,971 |
Notes Payable [Member] | ||
Debt Instrument [Line Items] | ||
Convertible Note payable | 3,000,000 | 3,000,000 |
Kopple Notes Payable-related party [Member] | ||
Debt Instrument [Line Items] | ||
Convertible Note payable | 10,909,742 | 10,494,933 |
Mel Gagerman Notes Payable [Member] | ||
Debt Instrument [Line Items] | ||
Convertible Note payable | $ 142,660 | $ 139,026 |
Notes Payable (Details 1) (Pare
Notes Payable (Details 1) (Parenthetical) - Notes Payable [Member] | Aug. 31, 2020USD ($) |
Debt Instrument [Line Items] | |
Notes payable interest rate | 5.00% |
Convertible notes payable | $ 700,000 |
Notes Payable (Details Textual)
Notes Payable (Details Textual) | Jul. 02, 2020 | Jan. 11, 2018 | Jun. 20, 2013USD ($)$ / shares | May 07, 2013USD ($)Notes$ / sharesshares | Oct. 02, 2012USD ($) | Aug. 10, 2012USD ($) | Apr. 23, 2020 | Sep. 30, 2018USD ($) | Feb. 14, 2018$ / shares | Jan. 30, 2017 | Aug. 31, 2020USD ($) | Aug. 31, 2019USD ($) | Aug. 31, 2020USD ($)shares | Aug. 31, 2019USD ($) | Feb. 29, 2020USD ($) | Feb. 28, 2019USD ($) | Feb. 28, 2018USD ($)shares | Jan. 24, 2017USD ($) |
Notes Payable (Textual) | ||||||||||||||||||
Paycheck protection plan loan, Description | We obtained a Paycheck Protection Program (“PPP”) loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred for six months, at which time the balance is payable in 18 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company intends to use the PPP loan proceeds for payroll, healthcare benefits, rent and other qualifying expenses. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. While we intend to apply for the forgiveness of the PPP Loan, there is no assurance that we will obtain forgiveness of the PPP Loan in whole or in part. As of August 31, 2020, $37,202 was classified as notes payable, non-current and $37,203 was classified as part of notes payable, current portion. | |||||||||||||||||
Gain on extinguishment of debt | $ (871,887) | $ (871,887) | ||||||||||||||||
Economic Injury Disaster Loan, description | The Company received cash proceeds of $149,900 under this program. The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include: interest accrues at 3.75% per annum effective July 1, 2020; the payment schedule contains a one-year deferral period on initial principle and interest payments; the loan term is thirty years; The Company pledged the assets of the Company as collateral for the loan; and there is no prepayment penalty or fees. As of August 31, 2020, the amount outstanding including accrued interest of $941 is $150,841 and is classified as part of notes payable, non-current on the August 31, 2020 balance sheet. | |||||||||||||||||
Director [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Debt amount | $ 23,872,614 | |||||||||||||||||
Conversion price per share of notes payable | $ / shares | $ 1.40 | |||||||||||||||||
Principle amount | 10,000 | |||||||||||||||||
Reverse stock split, description | 1-for-7 reverse stock split. | |||||||||||||||||
Notes maturity date, term | 5 years | |||||||||||||||||
Notes payable interest rate | 5.00% | 5.00% | ||||||||||||||||
Convertible Secured Notes [Member] | Dresner and Lempert [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Pre conversion debt principal amount | $ 200,000 | |||||||||||||||||
Conversion price per share of notes payable | $ / shares | $ 0.50 | |||||||||||||||||
Amortization of debt discount | $ 39,152 | |||||||||||||||||
Remaining principle and interest balance | 59,506 | $ 59,506 | ||||||||||||||||
Notes maturity date, term | 1 year | |||||||||||||||||
Convertible Secured Notes [Member] | Abdou and Abdou [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Pre conversion debt principal amount | $ 125,000 | |||||||||||||||||
Conversion price per share of notes payable | $ / shares | $ 0.50 | |||||||||||||||||
Amortization of debt discount | $ 24,470 | |||||||||||||||||
Remaining principle and interest balance | 180,000 | 215,000 | $ 125,000 | |||||||||||||||
Notes maturity date, term | 1 year | |||||||||||||||||
Repayment of loans | $ 125,000 | |||||||||||||||||
Judgment of approximately value plus legal fees | $ 235,000 | |||||||||||||||||
Amount of accrued interest | $ 125,000 | |||||||||||||||||
Convertible Debt [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Description of convertible promissory note | All of the creditors entered into the January 30, 2017 agreement with the exception of Mr. W. Abdou and Mr. M. Abdou. The original agreement dated May 7, 2013 provided that if at least 75% of the stock issuable upon conversion of the convertible notes votes to amend the agreement and/or waive any conditions or defaults, then any such amendments or waivers shall be binding on all secured creditors. The five secured creditors signing the amendment total in excess of 95% of the issuable stock upon conversion and, therefore the agreement is binding on all seven of the secured creditors. The agreement provided that all accrued and unpaid interest will be added to the principal amount. The amended note provided for no interest from November 1, 2016 to February 14, 2018, the date at which the 1-for-7 reverse stock split became effective at which time 80% of the total debt including accrued interest was converted into shares of common stock and a new five year 5% per annum convertible note was issued for the remainder. The new amended and restated senior convertible notes have a maturity date of January 30, 2022. The five creditors and the Company entered into a Second Amendment to Transaction Documents on March 14, 2017 and a Third Amendment to Transaction Documents on April 8, 2017, both of which extended the required date of the stockholder approval of the 1-for-7 reverse stock split, which approval was obtained in January 2018. The amended and restated senior convertible notes also require the Company to make a “Required Cash Payment” as defined in the agreement if the Company receives at least $4,000,000 in aggregate gross proceeds from the sale of equity securities (including securities convertible into equity securities) of the Company in one or a series of related transactions. The Required Cash Payment is equal to the current outstanding balance of the notes, which was approximately $1,005,000 as of August 31 and February 29, 2020, respectively, plus any outstanding accrued interest. | |||||||||||||||||
Demand Promissory Notes Payable [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Debt amount | $ 267,000 | |||||||||||||||||
Principle amount | 768,537 | |||||||||||||||||
Converted shares of common stock | shares | 192,641 | |||||||||||||||||
Repayment of loans | $ 267,000 | |||||||||||||||||
Aggregate reduction of current liabilities | 1,143,886 | 1,143,886 | ||||||||||||||||
LPD Investments, Ltd. [Member] | Convertible Secured Notes [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Pre conversion debt principal amount | $ 550,000 | |||||||||||||||||
Debt amount | $ 558,700 | |||||||||||||||||
Conversion price per share of notes payable | $ / shares | $ 0.75 | |||||||||||||||||
Amortization of debt discount | $ 175,793 | |||||||||||||||||
Remaining principle and interest balance | 163,677 | 163,677 | ||||||||||||||||
Number of notes payable to transferred | Notes | 2 | |||||||||||||||||
Notes maturity date, term | 1 year | |||||||||||||||||
Initial exercise price | $ / shares | $ 0.75 | |||||||||||||||||
Kenmont Capital Partners [Member] | Convertible Secured Notes [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Pre conversion debt principal amount | $ 1,000,000 | |||||||||||||||||
Debt amount | $ 1,087,000 | |||||||||||||||||
Conversion price per share of notes payable | $ / shares | $ 0.75 | |||||||||||||||||
Amortization of debt discount | $ 342,020 | |||||||||||||||||
Remaining principle and interest balance | 549,954 | 549,954 | ||||||||||||||||
Number of notes payable to transferred | Notes | 4 | |||||||||||||||||
Notes maturity date, term | 1 year | |||||||||||||||||
Initial exercise price | $ / shares | $ 0.75 | |||||||||||||||||
Refinancing Agreements [Member] | Convertible Secured Notes [Member] | Guenther [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Pre conversion debt principal amount | $ 750,000 | |||||||||||||||||
Conversion price per share of notes payable | $ / shares | $ 0.75 | |||||||||||||||||
Term of warrant | 7 years | |||||||||||||||||
Amortization of debt discount | $ 235,985 | |||||||||||||||||
Number of common shares entitlement on exercise of warrant one (in shares) | shares | 1,000,000 | |||||||||||||||||
Remaining principle and interest balance | 232,194 | 232,194 | ||||||||||||||||
Notes maturity date, term | 1 year | |||||||||||||||||
Initial exercise price | $ / shares | $ 0.75 | |||||||||||||||||
Unsecured Debt [Member] | Convertible Debt [Member] | Dalrymple [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Pre conversion debt principal amount | $ 500,000 | $ 1,000,000 | ||||||||||||||||
Amortization of debt discount | $ 310,723 | |||||||||||||||||
Remaining principle and interest balance | $ 137,583 | 264,462 | $ 264,462 | |||||||||||||||
Due date of notes | Jan. 11, 2023 | |||||||||||||||||
Notes maturity date, term | 5 years | 5 years | ||||||||||||||||
Notes payable interest rate | 5.00% | 7.00% | 7.00% | |||||||||||||||
Unsecured Debt [Member] | Convertible Debt One [Member] | Dalrymple [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Remaining principle and interest balance | 133,178 | |||||||||||||||||
Secured creditors September 2019 [Member] | Former Chief Executive Officers [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Debt amount | $ 325,000 | $ 325,000 | ||||||||||||||||
Demand Promissory Notes Payable [Member] | ||||||||||||||||||
Notes Payable (Textual) | ||||||||||||||||||
Description of convertible promissory note | In the second quarter of fiscal year 2021, liabilities with respect to $758,537 in principal plus $385,349 in accrued interest were reversed as the related statute of limitations were determined to have expired. | |||||||||||||||||
Issuance of common stock | shares | 192,641 | |||||||||||||||||
Gain on extinguishment of debt | $ 871,887 |
Accrued Expenses (Details)
Accrued Expenses (Details) - USD ($) | Aug. 31, 2020 | Feb. 29, 2020 |
Payables and Accruals [Abstract] | ||
Accrued payroll and related expenses | $ 600,508 | $ 1,868,928 |
Other accrued expenses | 77,442 | 77,362 |
Total | $ 682,950 | $ 1,946,290 |
Accrued Expenses (Details Textu
Accrued Expenses (Details Textual) | Aug. 31, 2020USD ($) |
Accrued Expenses (Textual) | |
Accrued payroll and related expenses | $ 1,300,000 |
Shareholders' Equity (Details)
Shareholders' Equity (Details) | 6 Months Ended |
Aug. 31, 2020$ / shares | |
Stockholders' Equity Note [Abstract] | |
Exercise Price | $ 0.25 |
Share Price | $ 0.16 |
Volatility % | 225.00% |
Risk-free rate | 0.57% |
Expected term (yrs.) | 4 years |
Shareholders' Equity (Details 1
Shareholders' Equity (Details 1) - 2006 Plan [Member] | 6 Months Ended |
Aug. 31, 2020USD ($)$ / sharesshares | |
Number of Shares | |
Number of Shares, Outstanding, February 29, 2020 | shares | 1,040,001 |
Number of Shares, Granted | shares | 1,250,000 |
Number of Shares, Exercised | shares | |
Number of Shares, Cancelled | shares | |
Number of Shares, Outstanding, August 31, 2020 | shares | 2,290,001 |
Exercise Prices | |
Exercise Prices, Outstanding, February 29, 2020 | $ 1.40 |
Exercise Prices, Granted | 0.25 |
Exercise Prices, Exercised | |
Exercise Prices, Cancelled | |
Exercise Price, Outstanding, August 31, 2020 | 0.77 |
Weighted Average Intrinsic Value | |
Weighted Average Intrinsic Value, Granted | |
Weighted Average Intrinsic Value, Exercised | $ | |
Weighted Average Intrinsic Value, Cancelled | |
Weighted Average Intrinsic Value, Outstanding, August 31, 2020 | $ |
Shareholders' Equity (Details 2
Shareholders' Equity (Details 2) - $1.40 [Member] | 6 Months Ended |
Aug. 31, 2020$ / sharesshares | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Stock Options Outstanding | shares | 2,290,001 |
Stock Options Exercisable | shares | 1,040,001 |
Weighted Average Remaining Contractual Life | 3 years 6 months |
Weighted Average Exercise Price of Options Outstanding | $ 0.77 |
Weighted Average Exercise Price of Options Exercisable | 1.40 |
Minimum [Member] | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of Exercise Price | 0.25 |
Maximum [Member] | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of Exercise Price | $ 1.40 |
Shareholders' Equity (Details 3
Shareholders' Equity (Details 3) | 6 Months Ended |
Aug. 31, 2020$ / sharesshares | |
Class of Warrant or Right [Line Items] | |
Exercise Prices, Outstanding, August 31, 2020 | $ 1.40 |
Warrants [Member] | |
Class of Warrant or Right [Line Items] | |
Number of Shares, Outstanding, February 29, 2020 | shares | 5,816,939 |
Number of Shares, Granted | shares | |
Number of Shares, Exercised | shares | |
Number of Shares, Cancelled | shares | |
Number of Shares, Outstanding, August 31, 2020 | shares | 5,816,939 |
Exercise Prices, Outstanding, February 28, 2019 | $ 1.40 |
Exercise Prices, Granted | |
Exercise Prices, Exercised | |
Exercise Prices, Cancelled | |
Exercise Prices, Outstanding, August 31, 2020 | $ 1.40 |
Shareholders' Equity (Details 4
Shareholders' Equity (Details 4) - $ / shares | 6 Months Ended | |
Aug. 31, 2020 | Feb. 29, 2020 | |
Class of Warrant or Right [Line Items] | ||
Range of Exercise Prices | $ 0.25 | |
Warrant [Member] | ||
Class of Warrant or Right [Line Items] | ||
Stock Warrants Outstanding | 5,816,939 | 5,816,939 |
Warrant [Member] | $1.40 [Member] | ||
Class of Warrant or Right [Line Items] | ||
Range of Exercise Prices | $ 1.40 | |
Stock Warrants Outstanding | 5,816,939 | |
Stock Warrants Exercisable | 5,816,939 | |
Weighted Average Remaining Contractual Life | 2 years 2 months 8 days | |
Weighted Average Exercise Price of Warrants Outstanding | $ 1.40 | |
Weighted Average Exercise Price of Warrants Exercisable | $ 1.40 |
Shareholders' Equity (Details T
Shareholders' Equity (Details Textual) - USD ($) | 3 Months Ended | 6 Months Ended | ||||
Aug. 31, 2020 | May 31, 2020 | Aug. 31, 2019 | May 31, 2019 | Aug. 31, 2020 | Aug. 31, 2019 | |
Shareholders' Equity (Textual) | ||||||
Common stock for cash | $ 580,000 | $ 235,000 | $ 100,353 | $ 50,000 | $ 815,000 | $ 150,353 |
Shares issued for debt settlement, shares | 192,641 | 1,030,385 | ||||
Shares issued for debt settlement | $ 329,723 | |||||
Warrants exercise price | $ 1.40 | $ 1.40 | ||||
Warrants exercise price, description | The aggregate fair value of the 1,250,000 options granted in March 2020 is $194,000, or $0.155 per option, with $96,477 and $174,076 recorded as part of sales, general and administration expense. | |||||
2011 Director and Executive Officers Stock Option Plan [Member] | ||||||
Shareholders' Equity (Textual) | ||||||
Employee stock options, description | Under the 2011 Plan, the Company may grant options for up to 15% of the number of shares of Common Stock of the Company from time to time outstanding, with a contractual option term of five-years, and a vesting period not less than six-months and one day following date of grant. In the six-months ended August 31, 2020, the Board of Directors approved grants of 250,000 stock options to each board member for an aggregate of 1,250,000 options, with an exercise price of $0.25 per option and at a market price of $0.16 on March 19, 2020. | |||||
2006 Employee Stock Option Plan [Member] | ||||||
Shareholders' Equity (Textual) | ||||||
Employee stock options, description | Under the 2006 Plan, the Company may grant options for up to the greater of three million or 10% of the number of shares of the Common Stock of Aura from time to time outstanding. As of February 29, 2020, and August 31, 2020, there were no stock options outstanding. | |||||
Common Stock [Member] | ||||||
Shareholders' Equity (Textual) | ||||||
Shares of common stock | 3,866,664 | 1,358,333 | 501,765 | 156,250 | 5,224,997 | 658,015 |
Common stock for cash | $ 387 | $ 135 | $ 51 | $ 15 |
Related Parties Transactions (D
Related Parties Transactions (Details) - USD ($) | 1 Months Ended | 6 Months Ended | |||
Nov. 20, 2020 | Feb. 14, 2018 | Aug. 31, 2020 | Feb. 29, 2020 | Jan. 24, 2017 | |
Related Parties Transactions (Textual) | |||||
Notes payable-related party | $ 3,000,000 | $ 3,000,000 | |||
Accrued interest-related party | 338,527 | 262,911 | |||
Notes payable and accrued interest-related party | 11,752,402 | 11,333,960 | |||
Accrued payroll and related expenses | $ 1,008,000 | ||||
Convertible Secured Notes [Member] | |||||
Related Parties Transactions (Textual) | |||||
Interest rate | 5.00% | ||||
Mr. Breslow [Member] | |||||
Related Parties Transactions (Textual) | |||||
Unsecured notes payable and accrued interest - related party | $ 14,982,041 | ||||
Debt amount | 23,872,614 | ||||
Convertible note payable and accrued interest-related party, net of discount | $ 9,388,338 | $ 8,890,574 | |||
New debt agreement, term | 5 years | ||||
Convertible note, amount | $ 11,982,041 | ||||
Convertible note, shares | 7,403,705 | ||||
Reverse stock split, description | 1-for-7 reverse stock split. | ||||
Interest rate | 5.00% | 5.00% | |||
Remaining balance | $ 3,000,000 | ||||
Conversion rate per share | $ 1.40 | ||||
CEO [Member] | Unsecured Debt [Member] | |||||
Related Parties Transactions (Textual) | |||||
Unsecured notes payable and accrued interest - related party | $ 82,000 | ||||
CEO [Member] | Accrued interest [Member] | |||||
Related Parties Transactions (Textual) | |||||
Unsecured notes payable and accrued interest - related party | $ 60,660 | ||||
Mr. Kopple [Member] | |||||
Related Parties Transactions (Textual) | |||||
Related party transaction, description | On August 19, 2013, the Company entered into an agreement with Robert Kopple, a former member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the “Kopple Notes”) and warrants. The Kopple Notes carried a base interest rate of 9.5%, have a 4-year maturity date and were convertible into shares of common stock at the conversion price of $3.50 per share (conversion feature expired in 2017). The warrants were subsequently exercised. The Company recorded $667,118 as a discount, which has been fully amortized. The Company also entered into a demand note payable with this individual in the amount of $20,000, which bears interest at a rate of 5% per annum. | ||||
Balance of principle and accrued interest | $ 10,909,742 | 10,494,933 | |||
Principle loan amount | 5,607,323 | 5,607,323 | |||
Mr. Kopple [Member] | Accrued interest [Member] | |||||
Related Parties Transactions (Textual) | |||||
Additional accrued interest | 5,302,419 | 4,887,610 | |||
Gagerman [Member] | |||||
Related Parties Transactions (Textual) | |||||
Unsecured notes payable and accrued interest - related party | $ 142,660 | ||||
Interest rate | 10.00% | ||||
Remaining balance | 139,026 | ||||
Jiangsu Shengfeng [Member] | |||||
Related Parties Transactions (Textual) | |||||
Related party transaction, description | Following this agreement which would consists of a non-interest-bearing promissory note and a payment plan pursuant to which the $700,000 would be paid over a 12-month period. Principal loan amount on August 31, 2020 and February 29, 2020 was $700,000, respectively, and is classified as part of notes payable and accrued interest-related party, current on the balance sheets as of August 31, 2020. | ||||
Companies return | $ 700,000 | ||||
Principle loan amount | $ 700,000 | $ 700,000 |
Commitments & Contingencies (De
Commitments & Contingencies (Details) | 1 Months Ended | 6 Months Ended | ||||
Mar. 26, 2019shares | Dec. 31, 2018USD ($) | May 31, 2018USD ($) | Aug. 31, 2020USD ($)ft² | Jul. 31, 2020ft² | Dec. 31, 2017USD ($) | |
Commitments & Contingencies (Textual) | ||||||
Area of facility (in square feet) | ft² | 1,000 | 20,000 | ||||
Contingencies description | The Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing Ronald Buschur as a member of the Company's Board and electing Cipora Lavut as a director of the Company. | |||||
Stockholders combined total | shares | 27,500,000 | |||||
Ongoing fees | $ 52,000 | |||||
Moving and delivery amount | $ 114,000 | |||||
Director [Member] | ||||||
Commitments & Contingencies (Textual) | ||||||
Secured debt, description | The Company is presently engaged in a dispute with one of its former directors, Robert Kopple, relating to approximately $10.6 million (representing approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced or paid to third parties on Aura's behalf; and approximately $5 million Mr. Kopple claims to be owed for interest, loan fees and late payment charges) and approximately 3.33 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company. | |||||
California labor board [Member] | ||||||
Commitments & Contingencies (Textual) | ||||||
Accrued salary and related charges | $ 238,000 | |||||
Storage Facility [Member] | ||||||
Commitments & Contingencies (Textual) | ||||||
Rent per month | $ 5,000 | |||||
Stanton Facility [Member] | ||||||
Commitments & Contingencies (Textual) | ||||||
Rent per month | $ 10,000 | |||||
Office Space [Member] | ||||||
Commitments & Contingencies (Textual) | ||||||
Area of facility (in square feet) | ft² | 300 | |||||
Rent per month | $ 2,350 | |||||
Offsite Storage Space [Member] | ||||||
Commitments & Contingencies (Textual) | ||||||
Rent per month | $ 2,500 |